XML 62 R50.htm IDEA: XBRL DOCUMENT v3.8.0.1
Emflaza asset acquisition - Estimated future amortization (Details) - Intellectual Property - Marathon Pharmaceuticals, LLC
$ in Thousands
Dec. 31, 2017
USD ($)
Finite-Lived Intangible Assets [Line Items]  
2018 $ 21,713
2019 21,713
2020 21,713
2021 21,713
2022 and thereafter 46,141
Total $ 132,993